Search clinical trials for: Growth Hormone and Propranolol

Total 28986 results

Affiliated Hospital of Jiangnan University

Completed

Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS

Growth Hormone Treatment | Phelan-McDermid Syndrome

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Corporacion Parc Tauli
Parc de Salut Mar

Completed

GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition

Prader-Willi Syndrome

Spain
Nemours Children's Clinic
EMD Serono; AstraZeneca; Genentech, Inc.

Completed

Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

Hypopituitarism

United States
Subhransu K. Ray, M.D., Ph.D.
Bay Area Retina Associates

Completed

A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD (Lucedex)

Exudative Age-Related Macular Degeneration

United States
Hoffmann-La Roche

Completed

A Study of Taspoglutide in Type 2 Diabetic Patients

Diabetes Mellitus Type 2

Germany
Hoffmann-La Roche

Completed

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Diabetes Mellitus Type 2

Australia, Hong Kong, Romania, Mexico, United States, Bulgaria, Germany, Latvia, Lithuania, Guatemala
Amsterdam UMC, location VUmc

Completed

GH and Cardiovascular Risk Factors

Cardiovascular Diseases | Physical Activity | Metabolic Syndrome | Growth Hormone Deficiency | Cognition

Netherlands
Oregon Health and Science University

Withdrawn

Low Dose Growth Hormone in Obese PCOS Women

Polycystic Ovary Syndrome

United States
GlaxoSmithKline

Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

China
University of Texas Southwestern Medical Center
Dana S Hardin

Withdrawn

Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis

Cystic Fibrosis
Woman's Health University Hospital, Egypt

Completed

Microflare Protocol in Poor Responders

Female Infertility Due to Diminished Ovarian Reserve

Egypt
Pacific Centre for Reproductive Medicine
EMD Serono

Terminated

Growth Hormone in Poor Responders to IVF Trial

Infertility

Canada
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma | Recurrent or Refractory

China
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Completed

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab (STAR)

Wet Macular Degeneration

Canada
Celgene

Completed

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

China
AEterna Zentaris

Completed

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

Multiple Myeloma

United States
Stichting Hemato-Oncologie voor Volwassenen Nederland

Active, not recruiting

Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM (HO147SMM)

Smouldering Myeloma

Netherlands, Norway, Czechia, Italy
Celgene

Completed

Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma (STRATUS)

Multiple Myeloma

Netherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
Celgene Corporation

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Ireland, Spain, Australia, Austria, United Kingdom
Seattle Children's Hospital

Terminated

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Hemangioma

United States
Assiut University

Unknown

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Ophthalmopathy

Egypt
Memorial Sloan Kettering Cancer Center
Celgene; Onyx/Amgen

Active, not recruiting

High Dose Carfilzomib for Newly Diagnosed Myeloma

Multiple Myeloma

United States
Fondazione EMN Italy Onlus

Active, not recruiting

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Multiple Myeloma

Italy
Kosin University Gospel Hospital
Celgene

Active, not recruiting

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone (LENDER)

Multiple Myeloma

Korea, Republic of
Fondazione Italiana Linfomi ONLUS

Active, not recruiting

Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL (FIL_KLIMT)

Mantle Cell Lymphoma

Italy
Celgene

Completed

Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year

Multiple Myeloma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

China
University of Sao Paulo
University of Sao Paulo General Hospital

Completed

Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma

Hemangioma

Brazil
University Hospital, Toulouse

Completed

Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?

Prader-Willi Syndrome | Growth Hormone Deficiency

France
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) (COMRADE-C)

Central Retinal Vein Occlusion | Macular Edema | Visual Impairment

Germany, United Kingdom, Hungary, Poland
University of Aarhus

Completed

Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.

Diabetes Mellitus Type I | Ketoacidosis

Denmark
Oregon Health and Science University

Withdrawn

Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.

Metabolic Syndrome

United States
Merck KGaA, Darmstadt, Germany

Completed

Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency

Growth Hormone Deficiency

France
Peking Union Medical College Hospital

Recruiting

Lenalidomide and Dexamethasone for Rosai-Dorfman Disease

Rosai-Dorfman Disease

China
IRCCS Policlinico S. Matteo

Completed

Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis

Primary Amyloidosis of Light Chain Type

Italy
Istituto Clinico Humanitas

Unknown

The Treatment of Lenalidomide in Patients With POEMS Syndrome

POEMS Syndrome

Italy
GeneScience Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology

Completed

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children (Phase 1)

Growth Hormone Deficiency
The Cleveland Clinic
Allergan

Completed

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema (PRECISION)

Diabetic Macular Edema

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.; Hartford Hospital

Completed

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Multiple Myeloma (MM)

United States
International Myeloma Foundation
Janssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.

Active, not recruiting

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT)

Smoldering Multiple Myeloma

United States
Oslo University Hospital
Nordic Myeloma Study Group

Active, not recruiting

Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. (CONPET)

Myeloma

Norway, Denmark, Sweden
Poitiers University Hospital
Sanofi; Celgene; Amgen; Intergroupe Francophone du Myelome

Active, not recruiting

Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory

France
Poitiers University Hospital
Sanofi; Intergroupe Francophone du Myelome

Active, not recruiting

Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).

Multiple Myeloma | Myeloma

France
Swiss Group for Clinical Cancer Research

Terminated

Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma (OptiPOM)

Refractory Multiple Myeloma

Switzerland
Mayo Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Giammaria Fiorentini

Unknown

TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer (EMBOBEVA)

Liver Metastasis Colon Cancer

Italy
Celgene

Completed

A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Japan
Celgene

Completed

A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea

Multiple Myeloma

Korea, Republic of
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital; Millennium Pharmaceuticals... and other collaborators

Completed

Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States

3

Subscribe